Analyst Ratings for NephroGenex, Inc. (NIRX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/11/2022 | Morgan Stanley | Terence Flynn | New Coverage | Equalweight (N/A) |
11.00 (N/A) |
8.26 (8.26) |
0% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/11/2022 | Morgan Stanley | Terence Flynn | New Coverage | Equalweight (N/A) |
11.00 (N/A) |
8.26 (8.26) |
0% | Details |